Pharmaceutical Commerce, a publication written for biopharma commercial executive decision-makers focusing on business processes and the technologies involved in how approved drugs go to market, included AssistRx in its June 2024 Adherence Aid: Real-World Evidence (RWE) and AI issue.
In “Combining RWE and AI to Bend the Adherence Curve,” AssistRx Vice President of Business Development Jordan Armstrong addresses the advantages of utilizing a stratified, omnichannel approach based on patient segmentation to improve patient uptake, adherence and outcomes.